المؤلفون: Morán-Mariños C; Unidad Especialidad en Tuberculosis, Servicio de Neumología, Hospital Nacional Dos de Mayo, Lima, Peru.; Unidad de Investigación en Bibliometría, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru., Llanos-Tejada F; Unidad Especialidad en Tuberculosis, Servicio de Neumología, Hospital Nacional Dos de Mayo, Lima, Peru., Salas-Lopez J; Unidad Especialidad en Tuberculosis, Servicio de Neumología, Hospital Nacional Dos de Mayo, Lima, Peru., Villanueva-Villegas R; Unidad Especialidad en Tuberculosis, Servicio de Neumología, Hospital Nacional Dos de Mayo, Lima, Peru.; Instituto de Investigaciones en Ciencias Biomédicas - INICIB, Facultad de Medicina, Universidad Ricardo Palma, Lima, Peru., Chavez-Huamani A; Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru., Vidal-Ruiz M; Unidad Especialidad en Tuberculosis, Servicio de Neumología, Hospital Nacional Dos de Mayo, Lima, Peru., Rodriguez-Calienes A; Neuroscience, Clinical Effectiveness and Public Health Research Group, Universidad Científica del Sur, Lima, Peru., Casanova-Mendoza R; Unidad Especialidad en Tuberculosis, Servicio de Neumología, Hospital Nacional Dos de Mayo, Lima, Peru.

المصدر: Medicine [Medicine (Baltimore)] 2024 Sep 27; Vol. 103 (39), pp. e39365.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Drug Hypersensitivity Syndrome*/etiology , Drug Hypersensitivity Syndrome*/drug therapy , Antitubercular Agents*/adverse effects , Antitubercular Agents*/therapeutic use , Desensitization, Immunologic*/methods, Humans ; Peru ; Retrospective Studies ; Female ; Male ; Adult ; Middle Aged ; Tuberculosis/drug therapy ; Algorithms

المؤلفون: Yoon JY; Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea., Kim TO; Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea., Kim JS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kim HW; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee EG; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Jung SS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea., Oh JY; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea., Kim JW; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee SH; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kim S; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kim SH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea., Park Y; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Min J; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kwon YS; Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea.

المصدر: PloS one [PLoS One] 2024 Sep 26; Vol. 19 (9), pp. e0309902. Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024).

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Pyrazinamide*/adverse effects , Pyrazinamide*/therapeutic use , Pyrazinamide*/administration & dosage , Antitubercular Agents*/adverse effects , Antitubercular Agents*/therapeutic use , Tuberculosis*/drug therapy, Humans ; Aged ; Male ; Female ; Retrospective Studies ; Aged, 80 and over ; Republic of Korea/epidemiology ; Treatment Outcome ; Prospective Studies ; Incidence

المؤلفون: Shimizu T; Department of Dermatology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. shimizu.t@tokai.ac.jp., Hirota A, Takahashi N, Okaniwa A, Saito R, Saito N, Kondoh A, Yamazaki F, Toshima S, Mabuchi T

المصدر: The Tokai journal of experimental and clinical medicine [Tokai J Exp Clin Med] 2024 Sep 20; Vol. 49 (3), pp. 101-104. Date of Electronic Publication: 2024 Sep 20.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Tokai University School Of Medicine Country of Publication: Japan NLM ID: 7704186 Publication Model: Electronic Cited Medium: Internet ISSN: 2185-2243 (Electronic) Linking ISSN: 03850005 NLM ISO Abbreviation: Tokai J Exp Clin Med Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/complications , Janus Kinase Inhibitors*/adverse effects , Antitubercular Agents*/adverse effects , Antitubercular Agents*/administration & dosage , Sulfonamides*/adverse effects , Sulfonamides*/administration & dosage , Pyrazoles*/adverse effects , Tuberculosis, Lymph Node*/drug therapy , Tuberculosis, Lymph Node*/diagnosis, Humans ; Female ; Aged ; Purines/adverse effects ; Purines/administration & dosage ; Azetidines/adverse effects ; Azetidines/administration & dosage ; Tuberculosis, Cutaneous/diagnosis ; Tuberculosis, Cutaneous/drug therapy ; Treatment Outcome ; Mycobacterium tuberculosis/isolation & purification ; Drug Therapy, Combination ; Isoniazid/adverse effects ; Isoniazid/administration & dosage

المؤلفون: Song Y; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Shu W; Clinical Center On TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Pei Y; Department of Tuberculosis, Changsha Central Hospital, Changsha, China., Du J; Department of Tuberculosis, Wuhan Pulmonary Hospital, Wuhan, China., Wu G; Department of Tuberculosis, Chengdu Public Health Clinical Center, Chengdu, China., Wang H; Department of Tuberculosis, Anhui Chest Hospital, Hefei, China., Mi F; Science and Technology Office, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China., Liu F; Science and Technology Office, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China., Ma L; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Xie L; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Kong Z; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Wu X; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Liu R; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Chen H; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Li H; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Ge Q; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Nie L; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Lv Z; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Huang X; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Li M; Department of Tuberculosis, The Third People's Hospital of Kunming, Kunming, China., Jiang M; Department of Tuberculosis, Chongqing Public Health Medical Center, Chongqing, China., Chen X; Department of Tuberculosis, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, China., Cai Q; Department of Tuberculosis, Hangzhou Red Cross Hospital, Hangzhou, China., Chen W; Department of Tuberculosis, Shenyang Tenth People's Hospital, Shenyang, China., Liu Y; Department of Tuberculosis, Tuberculosis Hospital of Jilin Province, Changchun, China., Miao Y; Department of Tuberculosis, The Forth People's Hospital of Taiyuan, Taiyuan, China., Tang Y; Department of Tuberculosis, Shaanxi Provincial Tuberculosis Prevention and Control Hospital, Xian, China., Chen Y; Department of Tuberculosis, Henan Provincial Infectious Diseases Hospital, Zhengzhou, China., Geng S; Department of Tuberculosis, Hebei Chest Hospital, Shijiazhuang, China., Zhou Q; Department of Tuberculosis, Lanzhou Pulmonary Hospital, Lanzhou, China., Liu Y; Clinical Center On TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Pang Y; Department of Bacteriology and Immunology, Beijing Key Laboratory On Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University/ /Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China. pangyupound@163.com., Gao M; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China. gaomqwdm@aliyun.com.

المصدر: BMC medicine [BMC Med] 2024 Sep 19; Vol. 22 (1), pp. 401. Date of Electronic Publication: 2024 Sep 19.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

مواضيع طبية MeSH: Clofazimine*/therapeutic use , Clofazimine*/administration & dosage , Tuberculosis, Multidrug-Resistant*/drug therapy , Linezolid*/therapeutic use , Linezolid*/administration & dosage , Diarylquinolines*/therapeutic use , Diarylquinolines*/administration & dosage , Cycloserine*/therapeutic use , Cycloserine*/administration & dosage , Levofloxacin*/therapeutic use , Levofloxacin*/administration & dosage , Antitubercular Agents*/administration & dosage , Antitubercular Agents*/therapeutic use , Rifampin*/therapeutic use , Rifampin*/administration & dosage, Humans ; Male ; Female ; Adult ; Middle Aged ; China/epidemiology ; Prospective Studies ; Drug Therapy, Combination ; Treatment Outcome ; Young Adult ; Aged

المؤلفون: Tanaka Y; Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan., Kobayashi T; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan., Shimizu S; Department of Pathology, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan., Kurahara Y; Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.; Department of Infectious Diseases, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan.

المصدر: Internal medicine (Tokyo, Japan) [Intern Med] 2024 Sep 15; Vol. 63 (18), pp. 2587-2588. Date of Electronic Publication: 2024 Feb 19.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Vasculitis, Leukocytoclastic, Cutaneous*/chemically induced , Vasculitis, Leukocytoclastic, Cutaneous*/drug therapy , Vasculitis, Leukocytoclastic, Cutaneous*/diagnosis , Vasculitis, Leukocytoclastic, Cutaneous*/complications , Tuberculosis, Pulmonary*/complications , Tuberculosis, Pulmonary*/drug therapy , Antitubercular Agents*/therapeutic use , Antitubercular Agents*/adverse effects, Humans ; Male ; Female ; Middle Aged

المؤلفون: Opperman M; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa., Mason S; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa., van der Westhuizen J; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa., Loots DT; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa., du Preez I; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa. Electronic address: Ilse.DuPreez@nwu.ac.za.

المصدر: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Sep 15; Vol. 248, pp. 116297. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents*/urine , Antitubercular Agents*/therapeutic use , Antitubercular Agents*/analysis , Treatment Failure* , Tuberculosis*/drug therapy , Tuberculosis*/urine, Humans ; Male ; Adult ; Female ; Proton Magnetic Resonance Spectroscopy/methods ; Middle Aged ; Pyrazinamide/urine ; Ethambutol/urine ; Magnetic Resonance Spectroscopy/methods ; Isoniazid/urine ; Aged

المؤلفون: Watson SJ, van der Watt ME, Theron A; Next Generation Health, Council for Scientific and Industrial Research, Pretoria 0001, South Africa., Reader J, Tshabalala S, Erlank E; Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Services, Wits Research Institute for Malaria, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Johannesburg 2000, South Africa., Koekemoer LL; Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Services, Wits Research Institute for Malaria, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Johannesburg 2000, South Africa., Naude M, Stampolaki M; Laboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis-Zografou, 15771 Athens, Greece., Adewole F; Department of Biological, Physical and Health Sciences, College of Science, Health & Pharmacy, Roosevelt University, 425 South Wabash Avenue, Chicago, Illinois 60605, United States., Sadowska K; Department of Biological, Physical and Health Sciences, College of Science, Health & Pharmacy, Roosevelt University, 425 South Wabash Avenue, Chicago, Illinois 60605, United States., Pérez-Lozano P; Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona 08028, Spain., Turcu AL; Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Barcelona E-08028, Spain., Vázquez S; Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Barcelona E-08028, Spain., Ko J; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States., Mazurek B; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States., Singh D; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States., Malwal SR; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States., Njoroge M; Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch, Capetown 7701, South Africa., Chibale K; Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch, Capetown 7701, South Africa.; South African Medical Research Council Drug Discovery and Development Centre, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, Capetown 7701, South Africa., Onajole OK; Department of Biological, Physical and Health Sciences, College of Science, Health & Pharmacy, Roosevelt University, 425 South Wabash Avenue, Chicago, Illinois 60605, United States., Kolocouris A; Laboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis-Zografou, 15771 Athens, Greece., Oldfield E; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States., Birkholtz LM

المصدر: ACS infectious diseases [ACS Infect Dis] 2024 Sep 13; Vol. 10 (9), pp. 3358-3367. Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Plasmodium falciparum*/drug effects , Antimalarials*/pharmacology , Antimalarials*/chemistry , Antitubercular Agents*/pharmacology , Antitubercular Agents*/chemistry , Adamantane*/pharmacology , Adamantane*/chemistry , Adamantane*/analogs & derivatives, Humans ; Structure-Activity Relationship ; Animals ; Malaria, Falciparum/drug therapy ; Malaria, Falciparum/parasitology ; Inhibitory Concentration 50 ; Ethylenediamines

المؤلفون: Marwitz F; Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center, Parkallee 1-40, Borstel 23845, Germany.; German Center for Infection Research, Thematic Translational Unit Tuberculosis, Borstel 23845, Germany., Hädrich G; Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2 ,Vienna 1090, Austria.; Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, Halle/Saale 06120, Germany., Redinger N; Cellular Microbiology, Research Center Borstel, Leibniz Lung Center, Parkallee 1-40 ,Borstel 23845, Germany., Besecke KFW; Rodos Biotarget GmbH, Feodor-Lynen-Straße 31, Hannover 30625, Germany.; Siegfried Hameln GmbH, Langes Feld 13 ,Hameln 31789, Germany.; Cardior Pharmaceuticals GmbH, Hollerithallee 20 ,Hannover 30419, Germany., Li F; Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2 ,Vienna 1090, Austria.; Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, Halle/Saale 06120, Germany.; Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences (PhaNuSpo), University of Vienna, Josef-Holaubek-Platz 2 ,Vienna 1090, Austria., Aboutara N; Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center, Parkallee 1-40, Borstel 23845, Germany.; German Center for Infection Research, Thematic Translational Unit Tuberculosis, Borstel 23845, Germany., Thomsen S; Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center, Parkallee 1-40, Borstel 23845, Germany., Cohrs M; Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, Halle/Saale 06120, Germany.; General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 ,Ghent 9000, Belgium., Neumann PR; Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, Halle/Saale 06120, Germany., Lucas H; Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, Halle/Saale 06120, Germany., Kollan J; Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, Halle/Saale 06120, Germany., Hozsa C; Rodos Biotarget GmbH, Feodor-Lynen-Straße 31, Hannover 30625, Germany.; Siegfried Hameln GmbH, Langes Feld 13 ,Hameln 31789, Germany., Gieseler RK; Rodos Biotarget GmbH, Feodor-Lynen-Straße 31, Hannover 30625, Germany.; Department of Medicine, University Hospital, Knappschaftskrankenhaus Bochum, Ruhr University Bochum, In der Schornau 23-25 ,Bochum 44892, Germany., Schwudke D; Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center, Parkallee 1-40, Borstel 23845, Germany.; German Center for Infection Research, Thematic Translational Unit Tuberculosis, Borstel 23845, Germany.; German Center for Lung Research (DZL), Airway Research Center North (ARCN), Research Center Borstel, Leibniz Lung Center, Borstel 23845, Germany.; Kiel Nano, Surface and Interface Sciences (KiNSIS), Kiel University, Kiel 24118, Germany., Furch M; Rodos Biotarget GmbH, Feodor-Lynen-Straße 31, Hannover 30625, Germany.; Certmedica International GmbH, Magnolienweg 17 ,Aschaffenburg 63741, Germany., Schaible U; German Center for Infection Research, Thematic Translational Unit Tuberculosis, Borstel 23845, Germany.; Cellular Microbiology, Research Center Borstel, Leibniz Lung Center, Parkallee 1-40 ,Borstel 23845, Germany., Dailey LA; Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2 ,Vienna 1090, Austria.

المصدر: ACS infectious diseases [ACS Infect Dis] 2024 Sep 13; Vol. 10 (9), pp. 3222-3232. Date of Electronic Publication: 2024 Aug 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Diarylquinolines*/pharmacokinetics , Diarylquinolines*/administration & dosage , Diarylquinolines*/chemistry , Diarylquinolines*/pharmacology , Liposomes*/chemistry , Antitubercular Agents*/administration & dosage , Antitubercular Agents*/pharmacokinetics , Antitubercular Agents*/pharmacology , Antitubercular Agents*/chemistry , Mice, Inbred BALB C* , Administration, Intranasal* , Mycobacterium tuberculosis*/drug effects, Animals ; Mice ; Female ; Lung/metabolism ; Lung/drug effects ; Fucose/chemistry ; Tuberculosis/drug therapy ; Disease Models, Animal ; Mice, Inbred C3H

المؤلفون: Samoon R; Department of Chemistry, School of Chemical and Life science, Jamia Hamdard, New Delhi 110062, India., Sau S; Department of Biological Sciences (Pharmacology and Toxicology), National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India., Roy A; Department of Biological Sciences (Pharmacology and Toxicology), National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India., Parida KK; Department of Biological Sciences (Pharmacology and Toxicology), National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India., Sharma K; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab 142001, India., Yakkala PA; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India., Dewangan RP; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India., Abdin MZ; Centre for Transgenic Plants, Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard India, New Delhi 110062, India., Kalia NP; Department of Biological Sciences (Pharmacology and Toxicology), National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India., Shafi S; Department of Chemistry, School of Chemical and Life science, Jamia Hamdard, New Delhi 110062, India.

المصدر: ACS infectious diseases [ACS Infect Dis] 2024 Sep 13; Vol. 10 (9), pp. 3320-3331. Date of Electronic Publication: 2024 Aug 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents*/pharmacology , Antitubercular Agents*/chemistry , Antitubercular Agents*/chemical synthesis , Mycobacterium tuberculosis*/drug effects , Benzothiazoles*/pharmacology , Benzothiazoles*/chemistry , Microbial Sensitivity Tests* , Bacterial Proteins*/antagonists & inhibitors , Bacterial Proteins*/metabolism, Humans ; Structure-Activity Relationship ; Molecular Docking Simulation ; Alcohol Oxidoreductases

المؤلفون: Jadhav K; Pharmaceutical Nanotechnology lab, Institute of Nano Science and Technology (INST), Sector-81, Mohali, Punjab, 140306, India. rahulverma@inst.ac.in., Jhilta A; Pharmaceutical Nanotechnology lab, Institute of Nano Science and Technology (INST), Sector-81, Mohali, Punjab, 140306, India. rahulverma@inst.ac.in., Singh R; Pharmaceutical Nanotechnology lab, Institute of Nano Science and Technology (INST), Sector-81, Mohali, Punjab, 140306, India. rahulverma@inst.ac.in., Ray E; Pharmaceutical Nanotechnology lab, Institute of Nano Science and Technology (INST), Sector-81, Mohali, Punjab, 140306, India. rahulverma@inst.ac.in., Kumar V; Experimental Animal Facility, ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, 282004, India., Yadav AB; Center of Biotechnology, Nehru Science Centre, University of Allahabad, Prayagraj-211002, India., Singh AK; Experimental Animal Facility, ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, 282004, India., Verma RK; Pharmaceutical Nanotechnology lab, Institute of Nano Science and Technology (INST), Sector-81, Mohali, Punjab, 140306, India. rahulverma@inst.ac.in.

المصدر: Nanoscale [Nanoscale] 2024 Sep 12; Vol. 16 (35), pp. 16485-16499. Date of Electronic Publication: 2024 Sep 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: RSC Pub Country of Publication: England NLM ID: 101525249 Publication Model: Electronic Cited Medium: Internet ISSN: 2040-3372 (Electronic) Linking ISSN: 20403364 NLM ISO Abbreviation: Nanoscale Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis, Central Nervous System*/drug therapy , Chitosan*/administration & dosage , Chitosan*/chemistry , Nanoparticles*/administration & dosage , Nanoparticles*/chemistry , Antitubercular Agents*/administration & dosage , Antitubercular Agents*/chemistry , Isoniazid*/administration & dosage , Rifampin*/administration & dosage, Animals ; Mice ; Blood-Brain Barrier ; Administration, Intranasal ; Epithelial Cells/drug effects ; Mice, Inbred BALB C ; Adhesives/administration & dosage ; Adhesives/chemistry ; Mucins/chemistry ; Brain/drug effects ; Brain/pathology ; Humans ; Cell Line ; Drug Delivery Systems